A Randomized PhaseII Trial of Neo-Adjuvant Chemotherapy with Metformin or Placebo for HER2 Positive Operable Breast Cancer The HERMET Trial Old Title: Randomized Trial of Neo-Adjuvant Chemotherapy with or without Metformin for HER2 Positive Operable Breast Cancer, The HERMET Trial

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03238495

Study #:
STUDY00140673

Start Date:
Aug 01, 2017

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03238495

View Complete Trial Details & Eligibility at ClinicalTrials.gov